CAFs Vs. TECs: when Blood Feuds Fuel Cancer Progression, Dissemination and Therapeutic Resistance

Overview

Journal Cell Oncol (Dordr)

Publisher Springer

Date 2024 Mar 7

PMID 38453816

Authors

Diane Coursier

Fernando Calvo

Affiliations

Soon will be listed here.

Abstract

Neoplastic progression involves complex interactions between cancer cells and the surrounding stromal milieu, fostering microenvironments that crucially drive tumor progression and dissemination. Of these stromal constituents, cancer-associated fibroblasts (CAFs) emerge as predominant inhabitants within the tumor microenvironment (TME), actively shaping multiple facets of tumorigenesis, including cancer cell proliferation, invasiveness, and immune evasion. Notably, CAFs also orchestrate the production of pro-angiogenic factors, fueling neovascularization to sustain the metabolic demands of proliferating cancer cells. Moreover, CAFs may also directly or indirectly affect endothelial cell behavior and vascular architecture, which may impact in tumor progression and responses to anti-cancer interventions. Conversely, tumor endothelial cells (TECs) exhibit a corrupted state that has been shown to affect cancer cell growth and inflammation. Both CAFs and TECs are emerging as pivotal regulators of the TME, engaging in multifaceted biological processes that significantly impact cancer progression, dissemination, and therapeutic responses. Yet, the intricate interplay between these stromal components and the orchestrated functions of each cell type remains incompletely elucidated. In this review, we summarize the current understanding of the dynamic interrelationships between CAFs and TECs, discussing the challenges and prospects for leveraging their interactions towards therapeutic advancements in cancer.

Citing Articles

Comprehensive multi-omics analysis and prognostic significance of fibroblast growth factor binding protein 1 (FGFBP1) in pancreatic adenocarcinoma.

Shao Z, Abdel-Maksoud M, Saleh I, Al-Hawadi J, Zomot N, Almutairi S Am J Transl Res. 2024; 16(8):4101-4119.

PMID: 39262727 PMC: 11384405. DOI: 10.62347/NCRX9798.

References

Egeblad M, Nakasone E, Werb Z . Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010; 18(6):884-901. PMC: 2905377. DOI: 10.1016/j.devcel.2010.05.012. View

Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins R, Chaudhry S . Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013; 15(6):637-46. PMC: 3836234. DOI: 10.1038/ncb2756. View

Enzerink A, Vaheri A . Fibroblast activation in vascular inflammation. J Thromb Haemost. 2011; 9(4):619-26. DOI: 10.1111/j.1538-7836.2011.04209.x. View

Yang T, Xiao H, Liu X, Wang Z, Zhang Q, Wei N . Vascular Normalization: A New Window Opened for Cancer Therapies. Front Oncol. 2021; 11:719836. PMC: 8406857. DOI: 10.3389/fonc.2021.719836. View

Wang Q, He Z, Huang M, Liu T, Wang Y, Xu H . Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α. Nat Commun. 2018; 9(1):559. PMC: 5805734. DOI: 10.1038/s41467-018-03050-0. View

Zeisberg E, Potenta S, Xie L, Zeisberg M, Kalluri R . Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007; 67(21):10123-8. DOI: 10.1158/0008-5472.CAN-07-3127. View

Dai J, Peng L, Fan K, Wang H, Wei R, Ji G . Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene. 2009; 28(38):3412-22. DOI: 10.1038/onc.2009.189. View

Wechman S, Emdad L, Sarkar D, Das S, Fisher P . Vascular mimicry: Triggers, molecular interactions and in vivo models. Adv Cancer Res. 2020; 148:27-67. PMC: 7594199. DOI: 10.1016/bs.acr.2020.06.001. View

Sokeland G, Schumacher U . The functional role of integrins during intra- and extravasation within the metastatic cascade. Mol Cancer. 2019; 18(1):12. PMC: 6337777. DOI: 10.1186/s12943-018-0937-3. View

10.

Ozdemir B, Pentcheva-Hoang T, Carstens J, Zheng X, Wu C, Simpson T . Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014; 25(6):719-34. PMC: 4180632. DOI: 10.1016/j.ccr.2014.04.005. View

11.

Chen M, Whisler J, Jeon J, Kamm R . Mechanisms of tumor cell extravasation in an in vitro microvascular network platform. Integr Biol (Camb). 2013; 5(10):1262-71. PMC: 4038741. DOI: 10.1039/c3ib40149a. View

12.

Perez-Gutierrez L, Ferrara N . Biology and therapeutic targeting of vascular endothelial growth factor A. Nat Rev Mol Cell Biol. 2023; 24(11):816-834. DOI: 10.1038/s41580-023-00631-w. View

13.

Bartoschek M, Oskolkov N, Bocci M, Lovrot J, Larsson C, Sommarin M . Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018; 9(1):5150. PMC: 6279758. DOI: 10.1038/s41467-018-07582-3. View

14.

Hashizume H, Baluk P, Morikawa S, McLean J, Thurston G, Roberge S . Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000; 156(4):1363-80. PMC: 1876882. DOI: 10.1016/S0002-9440(10)65006-7. View

15.

Sautes-Fridman C, Petitprez F, Calderaro J, Fridman W . Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019; 19(6):307-325. DOI: 10.1038/s41568-019-0144-6. View

16.

Cao Y, Cao R, Hedlund E . R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. J Mol Med (Berl). 2008; 86(7):785-9. DOI: 10.1007/s00109-008-0337-z. View

17.

Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. DOI: 10.1016/j.cell.2005.02.034. View

18.

Berthod F, Germain L, Tremblay N, Auger F . Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. J Cell Physiol. 2006; 207(2):491-8. DOI: 10.1002/jcp.20584. View

19.

Zhang Y, Cedervall J, Hamidi A, Herre M, Viitaniemi K, DAmico G . Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis. Cancer Res. 2020; 80(16):3345-3358. DOI: 10.1158/0008-5472.CAN-19-3533. View

20.

Akil A, Gutierrez-Garcia A, Guenter R, Rose J, Beck A, Chen H . Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective. Front Cell Dev Biol. 2021; 9:642352. PMC: 7928398. DOI: 10.3389/fcell.2021.642352. View